Eton Pharmaceuticals (ETON) grants 10,000 performance-vested RSUs to director
Rhea-AI Filing Summary
MAIER PAUL V reported acquisition or exercise transactions in this Form 4 filing.
Eton Pharmaceuticals director Paul V Maier received a grant of 10,000 performance-vested restricted stock units on July 31, 2026 under the company’s 2018 equity incentive plan. Each unit equals one share and vests in full if the stock’s closing price reaches $72.36 for one trading day before July 31, 2029; otherwise the award is forfeited. After the grant, he holds 10,000 units, the maximum and only number of shares issuable under this award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
MAIER PAUL V
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 10,000 shares (Direct)
Footnotes (1)
- F1. On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Key Figures
RSUs granted: 10,000 units
Vesting share price condition: $72.36 per share
Award forfeiture date: July 31, 2029
+2 more
5 metrics
RSUs granted
10,000 units
Performance-vested restricted stock units granted on July 31, 2026
Vesting share price condition
$72.36 per share
Closing price required for one trading day for the award to vest in full
Award forfeiture date
July 31, 2029
Date the award is forfeited if the market condition is not satisfied
Post-grant holdings
10,000 units
Total units held following the reported grant
Underlying share ratio
1 share per unit
Each restricted stock unit represents the right to acquire one share of common stock
Key Terms
performance-vested restricted stock units, equity incentive plan, market condition, closing price
4 terms
performance-vested restricted stock units financial
"the reporting person was granted 10,000 performance-vested restricted stock units"
equity incentive plan financial
"restricted stock units granted under the Issuer's 2018 equity incentive plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
market condition financial
"If this market condition is not satisfied prior to such date, the award will be forfeited"
closing price financial
"upon the closing price of the Issuer's common stock equaling or exceeding $72.36"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did ETON director Paul V Maier report?
Paul V Maier reported receiving a grant of 10,000 performance-vested restricted stock units from Eton Pharmaceuticals. The grant was made on July 31, 2026 under the 2018 equity incentive plan and represents the right to acquire up to 10,000 shares of common stock.
What are the vesting conditions for Paul V Maier’s 10,000 ETON restricted stock units?
The 10,000 restricted stock units vest in full only if Eton Pharmaceuticals’ stock closing price equals or exceeds $72.36 per share for one trading day. This market condition must be met before July 31, 2029, the third anniversary of the grant date.
What happens to Paul V Maier’s ETON award if the $72.36 price condition is not met?
If the $72.36 per share market condition is not satisfied for one trading day before July 31, 2029, the entire 10,000-unit award is forfeited without consideration. No shares are issued to Maier if the condition is not achieved in time.
Under which plan were Paul V Maier’s ETON restricted stock units granted?
The 10,000 performance-vested restricted stock units were granted under Eton Pharmaceuticals’ 2018 equity incentive plan. This plan governs the terms of the award, including the one-for-one share conversion and the $72.36 market condition vesting requirement.